Andrew Mirelman
Andrew Mirelman
PhD Candidate, Johns Hopkins School of Public Health
Verified email at jhsph.edu
Title
Cited by
Cited by
Year
Cost-effectiveness and economic benefits of vaccines in low-and middle-income countries: a systematic review
S Ozawa, A Mirelman, ML Stack, DG Walker, OS Levine
Vaccine 31 (1), 96-108, 2012
1792012
Tackling socioeconomic inequalities and non-communicable diseases in low-income and middle-income countries under the Sustainable Development agenda
LW Niessen, D Mohan, JK Akuoku, AJ Mirelman, S Ahmed, ...
The Lancet 391 (10134), 2036-2046, 2018
1442018
Using cost-effectiveness analysis to address health equity concerns
R Cookson, AJ Mirelman, S Griffin, M Asaria, B Dawkins, OF Norheim, ...
Value in Health 20 (2), 206-212, 2017
1262017
Estimated economic benefits during the ‘decade of vaccines’ include treatment savings, gains in labor productivity
ML Stack, S Ozawa, DM Bishai, A Mirelman, Y Tam, L Niessen, ...
Health affairs 30 (6), 1021-1028, 2011
952011
Health care priority setting in Norway a multicriteria decision analysis
T Defechereux, F Paolucci, A Mirelman, S Youngkong, G Botten, ...
BMC health services research 12 (1), 1-7, 2012
902012
Equity impacts of price policies to promote healthy behaviours
F Sassi, A Belloni, AJ Mirelman, M Suhrcke, A Thomas, N Salti, ...
The Lancet 391 (10134), 2059-2070, 2018
882018
Estimated economic impact of vaccinations in 73 low-and middle-income countries, 2001–2020
S Ozawa, S Clark, A Portnoy, S Grewal, ML Stack, A Sinha, A Mirelman, ...
Bulletin of the World Health Organization 95 (9), 629, 2017
812017
Empyema thoracis
AEH Ahmed, TE Yacoub
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine …, 2010
812010
Evaluating the 2014 sugar-sweetened beverage tax in Chile: an observational study in urban areas
R Nakamura, AJ Mirelman, C Cuadrado, N Silva-Illanes, J Dunstan, ...
PLoS medicine 15 (7), e1002596, 2018
752018
Voluntary medical male circumcision: strategies for meeting the human resource needs of scale-up in southern and eastern Africa
K Curran, E Njeuhmeli, A Mirelman, K Dickson, T Adamu, P Cherutich, ...
PLoS Med 8 (11), e1001129, 2011
712011
During the ‘decade of vaccines,’the lives of 6.4 million children valued at $231 billion could be saved
S Ozawa, ML Stack, DM Bishai, A Mirelman, IK Friberg, L Niessen, ...
Health affairs 30 (6), 1010-1020, 2011
702011
Decision-making criteria among national policymakers in five countries: a discrete choice experiment eliciting relative preferences for equity and efficiency
A Mirelman, E Mentzakis, E Kinter, F Paolucci, R Fordham, S Ozawa, ...
Value in health 15 (3), 534-539, 2012
682012
Effect of economic recession and impact of health and social protection expenditures on adult mortality: a longitudinal analysis of 5565 Brazilian municipalities
T Hone, AJ Mirelman, D Rasella, R Paes-Sousa, ML Barreto, R Rocha, ...
The Lancet Global Health 7 (11), e1575-e1583, 2019
632019
Why do some countries spend more for health? An assessment of sociopolitical determinants and international aid for government health expenditures
LL Liang, AJ Mirelman
Social Science & Medicine 114, 161-168, 2014
602014
Fiberoptic imaging of cavernous nerves in vivo
LB Boyette, MA Reardon, AJ Mirelman, TD Kirkley, JJ Lysiak, JB Tuttle, ...
The Journal of urology 178 (6), 2694-2700, 2007
472007
Multicriteria decision analysis to support health technology assessment agencies: benefits, limitations, and the way forward
R Baltussen, K Marsh, P Thokala, V Diaby, H Castro, I Cleemput, M Garau, ...
Value in Health 22 (11), 1283-1288, 2019
422019
Distribution of chronic disease mortality and deterioration in household socioeconomic status in rural Bangladesh: an analysis over a 24-year period
JAM Khan, AJ Trujillo, S Ahmed, AT Siddiquee, N Alam, AJ Mirelman, ...
International journal of epidemiology 44 (6), 1917-1926, 2015
342015
Projected health-care resource needs for an effective response to COVID-19 in 73 low-income and middle-income countries: a modelling study
TTT Edejer, O Hanssen, A Mirelman, P Verboom, G Lolong, OJ Watson, ...
The Lancet Global Health 8 (11), e1372-e1379, 2020
282020
The cost of illness attributable to diabetic foot and cost-effectiveness of secondary prevention in Peru
MK Cárdenas, AJ Mirelman, CJ Galvin, M Lazo-Porras, M Pinto, ...
BMC health services research 15 (1), 1-10, 2015
272015
Tackling NCD in LMIC: achievements and lessons learned from the NHLBI–UnitedHealth Global Health Centers of Excellence Program
MM Engelgau, UK Sampson, C Rabadan-Diehl, R Smith, J Miranda, ...
Global heart 11 (1), 5-15, 2016
262016
The system can't perform the operation now. Try again later.
Articles 1–20